(NASDAQ: SCLX) Scilex Holding Co's forecast annual revenue growth rate of 49.39% is forecast to beat the US Drug Manufacturers - General industry's average forecast revenue growth rate of 8.8%, and it is also forecast to beat the US market's average forecast revenue growth rate of 9.03%.
Scilex Holding Co's revenue in 2024 is $46,743,000.On average, 2 Wall Street analysts forecast SCLX's revenue for 2024 to be $15,901,043,413, with the lowest SCLX revenue forecast at $14,659,605,345, and the highest SCLX revenue forecast at $17,142,481,480. On average, 2 Wall Street analysts forecast SCLX's revenue for 2025 to be $16,410,415,257, with the lowest SCLX revenue forecast at $13,145,615,949, and the highest SCLX revenue forecast at $19,675,214,566.
In 2026, SCLX is forecast to generate $20,158,826,986 in revenue, with the lowest revenue forecast at $20,158,826,986 and the highest revenue forecast at $20,158,826,986.